Amplification and Selection of Antimicrobial Resistance in the Intestine II
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Antibiotic Selection Pressure
研究概览
简要总结
Stool samples will be collected from two groups of neutropenic patients in the case that a therapy with either meropenem or piperacillin/tazobactam is needed due to a suspected infection. The intestinal resistome will be determined and quantified using shotgun metagenomics. Based on this, regression models will be used to determine the actual selection pressure caused by these drugs, and both selective forces will be compared. The results will reveal if there is a drug that causes a lower selection pressure compared to the other. The study aims to generate knowledge that is required to design effective antibiotic stewardship programs.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with hemato-oncological disease in neutropenia or with expected neutropenia
- •Need for treatment with meropenem or piperacillin-tazobactam
排除标准
- •pregnancy
- •HIV, HBV, HCV
研究组 & 干预措施
Meropenem arm
Patients receiving meropenem to treat an infection.
干预措施: meropenem (Drug)
结局指标
主要结局
Antibiotic Selection Pressure
时间窗: under treatment, max. 10 days
Degree of the change of the intestinal resistome.
次要结局
未报告次要终点
研究者
Dr. Matthias Willmann
Prof. Dr. med.
University Hospital Tuebingen
